Physician profile
Lorraine Dodson
NPI 1619970761
$767.86
in general payments reported to CMS, 2019-2025
17 companies · $26.73 in 2025
The $26.73 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2021: $99.49 · 2022: $11.70 · 2023: $110 · 2024: $15.18 · 2025: $26.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $171.77 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $91.54 | 2023-2025 | |
| Pfizer INC. | $60.25 | 2019 | |
| Allergan, INC. | $58.92 | 2019 | |
| Therapeuticsmd, INC. | $57.17 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.34 | 2019-2021 | |
| Daiichi Sankyo INC. | $47.52 | 2019 | |
| Roche Diagnostics Corporation | $44.32 | 2019-2021 | |
| Astellas Pharma US INC | $39.79 | 2022-2023 | Veozah |
| Merck Sharp & Dohme LLC | $39.68 | 2019 | |
| Minerva Surgical, INC | $17.24 | 2023 | |
| Coopersurgical, INC. | $16.56 | 2019 | |
| Aesculap, INC. | $15.51 | 2019 | |
| Exeltis, USA INC. | $15.18 | 2024 | Slynd |
| Lupin INC. | $13.05 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $13.03 | 2019 | |
| Amgen INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorraine Dodson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.